Effects of Polymorphisms of the Sex Hormone-binding Globulin (SHBG) Gene on Free Estradiol and Bone Mineral Density

Overview

Journal Bone

Specialties Endocrinology
Orthopedics

Date 2009 Aug 15

PMID 19679209

Citations 11

Authors

Nicola Napoli

Ana Varadharajan

Giovam Batista Rini

Romano Del Fiacco

Jayasree Yarramaneni

Steven Mumm

Dennis T Villareal

Reina Armamento-Villareal

Affiliations

Soon will be listed here.

Abstract

Background: Polymorphisms of the sex hormone-binding globulin (SHBG) gene are associated with differences in SHBG levels, influencing the risk for breast cancer and polycystic ovarian syndrome, but no association has been reported for osteoporosis in postmenopausal women.

Objective: To determine the effect of G to A substitution in the 5'UTR (rs1799941) and the Asp356Asn (rs6259) polymorphisms of the SHBG gene on bone mineral density (BMD).

Methods: This is a cross-sectional study in a university-based research center from May, 2002 to December, 2007. A total of two hundred and thirteen healthy postmenopausal Caucasian women > or = 1 year from last menstrual period participated to this study. Serum estradiol by ultrasensitive radioimmnunoassay, serum sex hormone-binding globulin by immunoradiometric assay, and urinary NTx by enzyme-linked immunoassay were measured. BMD measurements were performed by dual energy X-ray absorptiometry and genotyping by Pyrosequencing.

Results: There were no significant differences in SHBG levels associated with either rs1799941 or rs6259. Using a p value of <0.00625 for significance, we found that subjects with the A allele (GA+AA) for the rs1799941, had a trend for lower free estradiol index (FEI) compared to the GG genotype (p=0.04). They also had significantly lower BMD at the intertrochanter (p=0.003) and trend for lower BMD at the total hip (p=0.02). There was no significant difference in FEI levels between the genotypes for the rs6259 polymorphism, but women with the Asn allele (Asp/Asn+Asn/Asn), had significantly lower BMD in the total femur (p=0.004) and intertrochanter (0.002) compared to those with the Asp/Asp genotype.

Conclusions: Our data suggest that polymorphisms of the SHBG gene are associated with significant differences in BMD at the proximal femur sites. Thus, genetic variations in the SHBG gene may influence BMD at the hip in postmenopausal women.

Citing Articles

Sex-specific differences in bone mineral density loss after sleeve gastrectomy.

Yang D, Ye Y, Tu Y, Xu R, Xiao Y, Zhang H Front Med (Lausanne). 2022; 9:957478.

PMID: 36388878 PMC: 9644159. DOI: 10.3389/fmed.2022.957478.

SHBG, Bone Mineral Density, and Physical Function Among Injection Drug Users With and Without HIV and HCV.

Dias J, Piggott D, Sun J, Wehbeh L, Garza J, Abraham A J Clin Endocrinol Metab. 2022; 107(7):e2971-e2981.

PMID: 35293996 PMC: 9202730. DOI: 10.1210/clinem/dgac144.

Genetically Predicted Sex Hormone-Binding Globulin and Bone Mineral Density: A Mendelian Randomization Study.

Qu Z, Jiang J, Yang F, Huang J, Zhao J, Yan S Calcif Tissue Int. 2020; 108(3):281-287.

PMID: 33068140 DOI: 10.1007/s00223-020-00770-8.

Genetic polymorphisms of the SHBG gene can be the effect on SHBG and HDL-cholesterol levels in Coronary Heart Disease: a case-control study.

Kurnaz-Gomleksiz O, Akadam-Teker B, Bugra Z, Omer B, Yilmaz-Aydogan H Mol Biol Rep. 2019; 46(4):4259-4269.

PMID: 31111369 DOI: 10.1007/s11033-019-04880-x.

Ovarian volume is associated with adiposity measures and bone mineral density in postmenopausal women.

Armeni E, Tsitoura A, Aravantinos L, Vakas P, Augoulea A, Rizos D J Musculoskelet Neuronal Interact. 2018; 18(4):501-508.

PMID: 30511954 PMC: 6313034.

References

Rosner W . The functions of corticosteroid-binding globulin and sex hormone-binding globulin: recent advances. Endocr Rev. 1990; 11(1):80-91. DOI: 10.1210/edrv-11-1-80. View

Eriksson A, Lorentzon M, Mellstrom D, Vandenput L, Swanson C, Andersson N . SHBG gene promoter polymorphisms in men are associated with serum sex hormone-binding globulin, androgen and androgen metabolite levels, and hip bone mineral density. J Clin Endocrinol Metab. 2006; 91(12):5029-37. DOI: 10.1210/jc.2006-0679. View

Armamento-Villareal R, Villareal D, Avioli L, Civitelli R . Estrogen status and heredity are major determinants of premenopausal bone mass. J Clin Invest. 1992; 90(6):2464-71. PMC: 443403. DOI: 10.1172/JCI116138. View

Xita N, Tsatsoulis A, Chatzikyriakidou A, Georgiou I . Association of the (TAAAA)n repeat polymorphism in the sex hormone-binding globulin (SHBG) gene with polycystic ovary syndrome and relation to SHBG serum levels. J Clin Endocrinol Metab. 2003; 88(12):5976-80. DOI: 10.1210/jc.2003-030197. View

Khosla S, Melton 3rd L, Riggs B . Clinical review 144: Estrogen and the male skeleton. J Clin Endocrinol Metab. 2002; 87(4):1443-50. DOI: 10.1210/jcem.87.4.8417. View

Gambera A, Scagliola P, Falsetti L, Sartori E, Bianchi U . Androgens, insulin-like growth factor-I (IGF-I), and carrier proteins (SHBG, IGFBP-3) in postmenopause. Menopause. 2004; 11(2):159-66. DOI: 10.1097/01.gme.0000086700.47410.2a. View

Haffner S, Katz M, Dunn J . Increased upper body and overall adiposity is associated with decreased sex hormone binding globulin in postmenopausal women. Int J Obes. 1991; 15(7):471-8. View

Toniolo P, Levitz M, Zeleniuch-Jacquotte A, Banerjee S, Koenig K, Shore R . A prospective study of endogenous estrogens and breast cancer in postmenopausal women. J Natl Cancer Inst. 1995; 87(3):190-7. DOI: 10.1093/jnci/87.3.190. View

Cummings S, Browner W, Bauer D, Stone K, Ensrud K, Jamal S . Endogenous hormones and the risk of hip and vertebral fractures among older women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1998; 339(11):733-8. DOI: 10.1056/NEJM199809103391104. View

10.

Khosla S . Editorial: Sex hormone binding globulin: inhibitor or facilitator (or both) of sex steroid action?. J Clin Endocrinol Metab. 2006; 91(12):4764-6. DOI: 10.1210/jc.2006-1990. View

11.

Hammond G . Potential functions of plasma steroid-binding proteins. Trends Endocrinol Metab. 1995; 6(9-10):298-304. DOI: 10.1016/1043-2760(95)00162-x. View

12.

Riancho J, Valero C, Zarrabeitia M, Garcia-Unzueta M, Amado J, Gonzalez-Macias J . Genetic polymorphisms are associated with serum levels of sex hormone binding globulin in postmenopausal women. BMC Med Genet. 2008; 9:112. PMC: 2615755. DOI: 10.1186/1471-2350-9-112. View

13.

Berrino F, Muti P, Micheli A, Bolelli G, Krogh V, Sciajno R . Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst. 1996; 88(5):291-6. DOI: 10.1093/jnci/88.5.291. View

14.

Mikulec K, Holloway L, Krasnow R, Javitz H, Swan G, Reed T . Relationship of endogenous sex hormones to coronary heart disease: a twin study. J Clin Endocrinol Metab. 2004; 89(3):1240-5. DOI: 10.1210/jc.2003-031333. View

15.

Forsti A, Jin Q, Grzybowska E, Soderberg M, Zientek H, Sieminska M . Sex hormone-binding globulin polymorphisms in familial and sporadic breast cancer. Carcinogenesis. 2002; 23(8):1315-20. DOI: 10.1093/carcin/23.8.1315. View

16.

Slemenda C, Longcope C, Peacock M, Hui S, JOHNSTON C . Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women. J Clin Invest. 1996; 97(1):14-21. PMC: 507057. DOI: 10.1172/JCI118382. View

17.

Kaaks R, Rinaldi S, Key T, Berrino F, Peeters P, Biessy C . Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer. 2005; 12(4):1071-82. DOI: 10.1677/erc.1.01038. View

18.

Wacholder S, Rothman N, Caporaso N . Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J Natl Cancer Inst. 2000; 92(14):1151-8. DOI: 10.1093/jnci/92.14.1151. View

19.

Paoletti A, Congia S, Lello S, Tedde D, Orru M, Pistis M . Low androgenization index in elderly women and elderly men with Alzheimer's disease. Neurology. 2004; 62(2):301-3. DOI: 10.1212/01.wnl.0000094199.60829.f5. View

20.

Zeleniuch-Jacquotte A, Shore R, Koenig K, Akhmedkhanov A, Afanasyeva Y, Kato I . Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study. Br J Cancer. 2004; 90(1):153-9. PMC: 2395327. DOI: 10.1038/sj.bjc.6601517. View